Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study
Titel:
Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study
Auteur:
Karpecki, Paul DePaolis, Michael Hunter, Judy A. White, Eric M. Rigel, Lee Brunner, Lynne S. Usner, Dale W. Paterno, Michael R. Comstock, Timothy L.